Abstract
PURPOSE: We updated an Uruguayan family with hereditary nonpolyposis colorectal cancer first described in 1977, incorporating knowledge of how thehMLH1 germline mutation has been established and shown to segregate in accord with the expected autosomal dominant mode of genetic transmission. METHODS: DNA-based molecular genetic testing was performed in conjunction with genetic counseling. Individuals were provided with their genetic test results, so that at-risk family members would be able to benefit from targeted management programs. RESULTS: We counseled 19 members of this kindred, 13 of whom were positive for thehMLH1 germline mutation. Specific recommendations for surveillance and management were provided. We were able to describe follow-up, including anecdotal cancer survival and pathology findings extending from the initial 1977 report of this family to the present. A remarkable sibship within this kindred was comprised of eight siblings, six of whom underwent resections for colorectal carcinoma between 1963 and 1971. Colon carcinomas before 1977 in this sibship were treated with classic hemicolectomies. Of those who had hemicolectomies for their first primary colorectal cancers, two had a second colon cancer primary, and two had a third colon cancer primary. CONCLUSIONS: Attention given to this extended family with hereditary nonpolyposis colorectal cancer has had a positive impact on the physician community in Uruguay, leading to the identification of additional families with hereditary nonpolyposis colorectal cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer 1996;78:1149–67.
Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997;93:84–99.
Fishel R, Lescoe MK, Rao MR,et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027–38.
Leach FS, Nicolaides NC, Papadopoulos N,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215–25.
Jass JR, Stewart SM, Schroeder D, Lane MR. Screening for hereditary nonpolyposis colorectal cancer in New Zealand. Eur J Gastroenterol Hepatol 1992;4:523–7.
Nicolaides NC, Papadopoulos N, Liu B,et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75–80.
Palombo F, Gillinari P, Iaccarino I,et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995;268:1912–4.
Peltomäki P, Vasen HF, International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology 1997;113:1146–58.
Peltomäki P, Sistonen P, Mecklin J-P,et al. Evidence supporting exclusion of the DCC gene and portion of chromosome 18q as the locus for susceptibility to hereditary nonpolyposis colorectal carcinoma in five kindreds. Cancer Res 1991;51:4135–40.
Peltomäki P, Lothe RA, Aaltonen LA,et al. Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res 1993;53:5853–5.
Peltomäki P. DNA mismatch repair gene mutations in human cancer. Environ Health Perspect 1997;105(Suppl 4):775–80.
Sarroca C, Ferreira WA, Quadrelli R. Cáncer colónico familiar sin poliposis: enfoque clínico y anátomopatológico. Perspectivas de estudio genético. Cir del Uruguay 1977;47:515–20.
Liu B, Parsons R, Papadopoulos N,et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169–74.
Chadwick RB, Conrad MP, McGinnis MD, Johnston-Dow L, Spurgeon SL, Kronick MN. Heterozygote and mutation detection by direct automatic fluorescent DNA sequencing using a mutant Taq DNA polymerase. Biotechniques 1996;20:676–83.
Liu B, Nicolaides NC, Markowitz S,et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995;9:48–55.
Tsakraklides V, Anastassiades OT, Kersey JH. Prognostic significance of regional lymph node histology in uterine cervical cancer. Cancer 1973;31:860–8.
Berlinger NT, Tsakraklides V, Pollak K, Adams GL, Yang M, Good RA. Immunologic assessment of regional lymph node histology in relation to survival in head and neck carcinoma. Cancer 1976;37:697–705.
Itoh H, Houlston RS, Harocopos C, Slack J. Risk of cancer death in first-degree relatives of patients with hereditary nonpolyposis cancer syndrome (Lynch Type II): a study of 130 kindreds in the United Kingdom. Br J Surg 1990;77:1367–70.
Vasen HF, Hartog Jager FC, Menko FH, Nagengast FM. Screening for hereditary nonpolyposis colorectal cancer: a study of 22 kindreds in the Netherlands. Am J Med 1989;86:278–81.
Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L. Familial aggregation of tumors in the three year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344–8.
Cristofaro G, Lynch HT, Caruso ML,et al. New phenotypic aspects in a family with Lynch syndrome II. Cancer 1987;60:51–8.
Abusamra H, Maximova S, Bar-Meir S, Krispin M, Rotmensch HH. Cancer family syndrome of Lynch. Am J Med 1987;83:981–3.
Mecklin J-P, Järvinen HJ, Peltokallio P. Cancer family syndrome: genetic analysis of 22 Finnish kindreds. Gastroenterology 1986;30:328–33.
Miyaki M, Konishi M, Tanaka K,et al. Germline mutation ofMSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997;17:271–2.
Järvinen HJ, Mecklin J-P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405–11.
Vasen HF, van Ballegooijen M, Buskens E,et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998;82:1632–7.
Lynch HT. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 1996;39:109–10.
Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med 1996;28:479–82.
Watson P, Lin K, Rodriguez-Bigas MA,et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal cancer family members. Cancer 1998;83:259–66.
Author information
Authors and Affiliations
Additional information
Supported by Grant #EDT-84 from the American Cancer Society, Grant #1RO1 CA74684-01 from the National Institutes of Health/National Cancer Institute, and a grant from the Nebraska State Cancer and Smoking-Related Diseases Research Program (LB595).
About this article
Cite this article
Sarroca, C., Alfano, N., Tedesco Bendin, G. et al. Hereditary nonpolyposis colorectal cancer (lynch syndrome II) in Uruguay. Dis Colon Rectum 43, 353–360 (2000). https://doi.org/10.1007/BF02258301
Issue Date:
DOI: https://doi.org/10.1007/BF02258301